News

I grew up and began my career in Brazil, where access to health care and education—especially in low-resource settings—was ...
The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...
COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication ...
Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...
It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...
Three reviews ranging in quality from medium to low described a positive impact of patient or family education that focused on medication reconciliation: improved medication administration ...
One factor is exposure to carbon from smoking or breathing polluted air. “We wanted to study what happens in the lungs of COPD patients when this carbon builds up in alveolar macrophage cells, as this ...
UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year ...
Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE ...
Abstract and Introduction Abstract Background: The clinical trial safety database for tiotropium has been augmented with a 4-year trial in patients with COPD, which provides an opportunity to ...